Viracta Therapeutics, Inc.股价重挫12.60% 市值跌34.06万美元

市场透视02-04

北京时间2025年02月04日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现异动，股价快速下跌12.60%。截至发稿，该股报0.068美元/股，成交量64.8746万股，换手率1.63%，振幅12.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.06...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2508572064?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-04 22:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2508572064","market":"us","top_or_hot":-1,"title":"Viracta Therapeutics, Inc.股价重挫12.60% 市值跌34.06万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年02月04日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现异动，股价快速下跌12.60%。截至发稿，该股报0.068美元/股，成交量64.8746万股，换手率1.63%，振幅12.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.06...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224700a2392c17&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viracta Therapeutics, Inc.股价重挫12.60% 市值跌34.06万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViracta Therapeutics, Inc.股价重挫12.60% 市值跌34.06万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-04 22:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224700a2392c17&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月04日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现异动，股价快速下跌12.60%。截至发稿，该股报0.068美元/股，成交量64.8746万股，换手率1.63%，振幅12.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.06...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224700a2392c17&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224700a2392c17&s=b","article_id":"2508572064","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224700a2392c17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2508572064","pubTimestamp":1738680420,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月04日22时47分，Viracta Therapeutics, Inc.股票出现异动，股价快速下跌12.60%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1240.81%、805.94%、195.64%，振幅较大的相关个股有Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025、Invivyd, Inc.，振幅分别为48.04%、40.00%、29.25%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Viracta Therapeutics, Inc. 's stock plunges 12.60%, its market value falls by $340,600","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIRX":1,"LENZ":1},"content_text":"北京时间2025年02月04日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现异动，股价快速下跌12.60%。截至发稿，该股报0.068美元/股，成交量64.8746万股，换手率1.63%，振幅12.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.06倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1240.81%、805.94%、195.64%，振幅较大的相关个股有Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025(To Pur Com)、Invivyd, Inc.，振幅分别为48.04%、40.00%、29.25%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。该公司正在为其组合产品候选药物进行三项临床试验，作为治疗复发/难治性Epstein-Barr病毒阳性淋巴瘤的潜在疗法。该公司的产品候选药物是一种组合产品候选药物，由nanatinostat（一种强效且选择性的I类组蛋白去乙酰化酶（HDAC）小分子抑制剂）和valganciclovir（一种经FDA批准的抗病毒药物，用于治疗和预防器官移植中由巨细胞病毒（CMV）引起的疾病）组成。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2508572064","isCrawlerRequest":true}